Turn this role into an interview — a resume and cover letter built around what this employer wants.
Pharmaron Hoddesdon is recruiting a Study Manager to lead Accelerator Mass Spectrometry studies, including mass balance, metabolite profiling and IVPK. You will manage timelines, reports and QA reviews, coordinating with clients and internal teams.
The role requires a PhD/MSc/BSc in chemistry or related field, experience in GxP environments, and a track record in drug discovery or development. Mentoring and continuous improvement duties are included.
Position:Study Manager- Accelerator Mass Spectrometry
Pharmaron is a global CRO helping pharma and biotech companies bring new therapies to life. With over 25,000 employees worldwide across 23 locations in the US, UK and China, we support drug discovery through to manufacturing with fully integrated, high-quality services.
We’re proud of the impact we make and just last year, we supported over 780 discovery projects, 1,000+ CMC programmes, and 1,000+ clinical trials across all phases. Our teams are involved in everything from small molecules to biologics and gene therapies, and we work with more than 3,000 global customers. To learn more, visit www.pharmaron.com.
Pharmaron is currently looking to recruit a Study Manager to join the - Accelerator Mass Spectrometry (AMS) team at our Hodlesdon site. In this role, you will be responsible for managing clinical AMS enabled studies, including mass balance, metabolite profiling and identification and IVPK (absolute bioavailability).
Collaborative Culture: Thrive in our inclusive and collaborative environment, where teamwork and innovation go hand in hand. Here, your voice matters, and your contributions make a real impact. "Employees Number One" and "Clients Centered" are the core cultural values at Pharmaron. Our culture, which sets Pharmaron apart from other organizations, has evolved from our deep commitment to our employees, partners and collaborators.
Pharmaron is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities and established a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities, including small molecules, biologics, and CGT products. With over 21,000 employees and operations in the U.S., the U.K. and China. Pharmaron has an excellent track record in delivering R&D solutions to its partners in North America, Europe, Japan, and China.